Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
Jing Pan, Kaiting Tang, Yuechen Luo, Samuel Seery, Yue Tan, Biping Deng, Feng Liu, Xiuwen Xu, Zhuojun Ling, Weiliang Song, Jinlong Xu, Jiajia Duan, Zelin Wang, Chunyu Li, Kai Wang, Yi-Bing Zhang, Xinjian Yu, Qinlong Zheng, Liping Zhao, Jiecheng Zhang, Alex H. Chang, Xiaoming Feng
Topics & Concepts
MedicineMinimal residual diseaseAdverse effectInternal medicineRefractory (planetary science)CD22Clinical endpointAcute lymphocytic leukemiaGastroenterologyPhases of clinical researchChimeric antigen receptorCD20HematologyCytokine release syndromeOncologyImmunologyClinical trialLeukemiaLymphomaImmunotherapyCancerBiologyAstrobiologyLymphoblastic LeukemiaCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchCutaneous lymphoproliferative disorders research